New Jersey 2022-2023 Regular Session

New Jersey Senate Bill S233

Introduced
1/11/22  

Caption

Provides for certain group home licensees to obtain Medicaid reimbursement for reservation of beds used by residents on therapeutic leave.

Impact

The enactment of S233 would positively impact state laws related to Medicaid and the operation of group homes. By mandating reimbursement for reserved beds, it encourages group homes to support the mental and emotional well-being of their residents, aligning with best practices in care for individuals with developmental disabilities. This creates a more stable environment for residents, allowing them to engage in therapeutic experiences away from the home without the fear of losing their accommodations.

Summary

Senate Bill S233 aims to enhance the support for residents of group homes for individuals with developmental disabilities by allowing group home licensees to receive Medicaid reimbursement for reserving beds when residents are on therapeutic leave. This leave is defined as a temporary absence for non-medical reasons, such as family visits or vacations, and is crucial for the well-being of such individuals. The bill specifies a framework in which the group home must hold the bed for up to 12 days annually while the resident is away, ensuring that the resident's accommodation is guaranteed during their time off.

Contention

Notable points of contention may arise regarding the implementation of the reimbursement process and the criteria for defining therapeutic leave. Provisions that restrict reimbursement to instances where residents are absent for a full 24-hour period could be scrutinized as potentially restrictive. Additionally, there may be concerns about the administrative burden placed on group homes to maintain accurate records of therapeutic leave, report these absences to state agencies, and navigate the reimbursement process effectively.

Companion Bills

No companion bills found.

Previously Filed As

NJ S3085

Increases the Medicaid reimbursement rate for Tier C services in licensed assisted living residences by 13% starting January 1, 2027.

NJ SB909

Relating to Medicaid reimbursement rates for certain mental health diagnostic and therapeutic procedures

NJ A3591

Requires NJ FamilyCare reimbursement for pediatric medication management services provided for certain children by licensed pharmacist.

NJ S0255

Establishes Medicaid fee-for-service reimbursement rates set by the general assembly as the rate floor for Medicaid managed care by home care, home nursing care and hospice providers licensed by the DOH and continue the EEOHH.

NJ SB1109

Short-term residential therapeutic programs.

NJ S438

Establishes minimum Medicaid reimbursement rate for structured day program services provided to beneficiary eligible for brain injury services.

NJ H5774

Establishes Medicaid fee-for-service reimbursement rates set by the general assembly as the rate floor for Medicaid managed care by home care, home nursing care and hospice providers licensed by the DOH and continue the EEOHH.

NJ S2363

Establishes the Medicaid fee-for-service reimbursement rates set by the general assembly as the rate floor for Medicaid managed care by home care, home nursing care and hospice providers.

NJ H8218

Establishes the Medicaid fee-for-service reimbursement rates set by the general assembly as the rate floor for Medicaid managed care by home care, home nursing care and hospice providers.

NJ A4654

Regulates medication administration in certain licensed, residential facilities.

Similar Bills

AL SB161

Medicaid; establishing coverage parity between opioid and nonopioid pain medications.

LA HB927

Provides relative to the Medicaid Pharmaceutical and Therapeutics Committee

MS SB2045

HIV medications; prohibit health plans and Medicaid from restricting dispensing of HIV/AIDS treatment.

MS SB2134

HIV medications; prohibit health plans and Medicaid from restricting dispensing of HIV/AIDS treatment.

FL S0070

Step-therapy Protocols

IL HB2584

INS-PRIOR AUTH HIV DRUG ACCESS

FL S1758

Public Assistance

MS HB1370

Nurse practitioners; authorize to prescribe therapeutic shoes for persons with diabetes.